|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income/(loss) | |||||
| Net loss from discontinued operation, net of tax | |||||
| Net income from continuing operation | |||||
| Adjustment to reconcile net (loss)/income to net cash used in operating activities | |||||
| Depreciation and amortization | |||||
| Amortization of operating lease right-of-use asset | |||||
| Allowance/(Reversal) for doubtful accounts | |||||
| Provision of advances to suppliers | |||||
| Other income | |||||
| Gain on disposal of subsidiaries | |||||
| Class A Ordinary Shares issued for consulting services | |||||
| Amortization of convertible note issuance costs | |||||
| Deferred tax expenses | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Advances to suppliers | |||||
| Prepayment and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other payables | |||||
| Income tax payable | |||||
| Advances from customers | |||||
| Operating lease liabilities | |||||
| Net cash (used in)/provided by operating activities from continuing operations | |||||
| Net cash (used in)/provided by operating activities from discontinuing operations | |||||
| Net cash (used in)/provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from disposal of subsidiaries | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Net cash provided by/(used in) investing activities from continuing operations | |||||
| Net cash provided by/(used in) investing activities from discontinuing operations | |||||
| Net cash provided by/(used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Issuance of ordinary shares for cash, net of issuance costs | |||||
| Proceeds from related parties | |||||
| Repayments to related parties | |||||
| Net cash provided by/(used in) financing activities from continuing operations | |||||
| Net cash provided by/(used in) financing activities from discontinuing operations | |||||
| Net cash provided by/(used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents of continuing operations–end of year | |||||
| Reconciliation of cash, cash equivalents and restricted cash, end of year | |||||
| Cash, cash equivalents | |||||
| Restricted cash | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow information | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash investing and financing activities | |||||
| Additions of ROU Assets | |||||
| Receivable from sale of subsidiaries | |||||
| Less cash, cash equivalents and restricted cash of discontinued operations–end of period | |||||
| Cash, cash equivalents and restricted cash of continuing operations–end of period | |||||
| Reconciliation of cash, cash equivalents and restricted cash, beginning of the year | |||||
| Cash, cash equivalents | |||||
| Restricted cash | |||||
Loading...